{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T21:17:58Z","timestamp":1793827078086,"version":"4.6.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"7771","license":[{"start":{"date-parts":[[2019,8,21]],"date-time":"2019-08-21T00:00:00Z","timestamp":1566345600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,8,21]],"date-time":"2019-08-21T00:00:00Z","timestamp":1566345600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nature"],"published-print":{"date-parts":[[2019,8,29]]},"DOI":"10.1038\/s41586-019-1501-z","type":"journal-article","created":{"date-parts":[[2019,8,21]],"date-time":"2019-08-21T14:02:44Z","timestamp":1566396164000},"page":"665-669","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":284,"title":["Microbiota-derived lantibiotic restores resistance against vancomycin-resistant Enterococcus"],"prefix":"10.1038","volume":"572","author":[{"given":"Sohn G.","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Becattini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas U.","family":"Moody","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavel V.","family":"Shliaha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric R.","family":"Littmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Seok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mergim","family":"Gjonbalaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Eaton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Fontana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Amoretti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Wright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Caballero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhong-Min X.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hea-Jin","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sejal M.","family":"Morjaria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid M.","family":"Leiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weige","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruben J. J. F.","family":"Ramos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin R.","family":"Cross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seiko","family":"Narushima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenya","family":"Honda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan U.","family":"Peled","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald C.","family":"Hendrickson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Taur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcel R. M.","family":"van den Brink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric G.","family":"Pamer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,8,21]]},"reference":[{"key":"1501_CR1","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/j.cell.2017.04.027","volume":"169","author":"F Lebreton","year":"2017","unstructured":"Lebreton, F. et al. Tracing the enterococci from Paleozoic origins to the hospital. Cell 169, 849\u2013861 (2017).","journal-title":"Cell"},{"key":"1501_CR2","unstructured":"Gilmore, M., Clewell, D., Ike, Y. & Shankar, N. Enterococci: From Commensals to Leading Causes of Drug Resistant Infection (Massachusetts Eye and Ear Infirmary, 2014)."},{"key":"1501_CR3","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1016\/j.chom.2017.04.002","volume":"21","author":"S Caballero","year":"2017","unstructured":"Caballero, S. et al. Cooperating commensals restore colonization resistance to vancomycin-resistant Enterococcus faecium. Cell Host Microbe 21, 592\u2013602.e594, (2017).","journal-title":"Cell Host Microbe"},{"key":"1501_CR4","unstructured":"U.S. Department of Health and Human Services. Antibiotic Resistance Threats in the United States, 2013\u00a0\n                    https:\/\/www.cdc.gov\/drugresistance\/biggest_threats.html\n                    \n                   (2013)."},{"key":"1501_CR5","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1126\/science.aad9382","volume":"352","author":"EG Pamer","year":"2016","unstructured":"Pamer, E. G. Resurrecting the intestinal microbiota to combat antibiotic-resistant pathogens. Science 352, 535\u2013538 (2016).","journal-title":"Science"},{"key":"1501_CR6","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1111\/imr.12563","volume":"279","author":"S Kim","year":"2017","unstructured":"Kim, S., Covington, A. & Pamer, E. G. The intestinal microbiota: antibiotics, colonization resistance, and enteric pathogens. Immunol. Rev. 279, 90\u2013105 (2017).","journal-title":"Immunol. Rev."},{"key":"1501_CR7","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1056\/NEJMoa1205037","volume":"368","author":"E van Nood","year":"2013","unstructured":"van Nood, E. et al. Duodenal infusion of donor feces for recurrent Clostridium difficile. N. Engl. J. Med. 368, 407\u2013415 (2013).","journal-title":"N. Engl. J. Med."},{"key":"1501_CR8","doi-asserted-by":"publisher","first-page":"e1002995","DOI":"10.1371\/journal.ppat.1002995","volume":"8","author":"TD Lawley","year":"2012","unstructured":"Lawley, T. D. et al. Targeted restoration of the intestinal microbiota with a simple, defined bacteriotherapy resolves relapsing Clostridium difficile disease in mice. PLoS Pathog. 8, e1002995 (2012).","journal-title":"PLoS Pathog."},{"key":"1501_CR9","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1038\/nature13828","volume":"517","author":"CG Buffie","year":"2015","unstructured":"Buffie, C. G. et al. Precision microbiome reconstitution restores bile acid mediated resistance to Clostridium difficile. Nature 517, 205\u2013208 (2015).","journal-title":"Nature"},{"key":"1501_CR10","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.1084\/jem.20170495","volume":"214","author":"S Becattini","year":"2017","unstructured":"Becattini, S. et al. Commensal microbes provide first line defense against Listeria monocytogenes infection. J. Exp. Med. 214, 1973\u20131989 (2017).","journal-title":"J. Exp. Med."},{"key":"1501_CR11","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1016\/j.cell.2018.08.047","volume":"174","author":"J Suez","year":"2018","unstructured":"Suez, J. et al. Post-antibiotic gut mucosal microbiome reconstitution is impaired by probiotics and improved by autologous FMT. Cell 174, 1406\u20131423 (2018).","journal-title":"Cell"},{"key":"1501_CR12","doi-asserted-by":"publisher","first-page":"4332","DOI":"10.1172\/JCI43918","volume":"120","author":"C Ubeda","year":"2010","unstructured":"Ubeda, C. et al. Vancomycin-resistant Enterococcus domination of intestinal microbiota is enabled by antibiotic treatment in mice and precedes bloodstream invasion in humans. J. Clin. Invest. 120, 4332\u20134341 (2010).","journal-title":"J. Clin. Invest."},{"key":"1501_CR13","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1093\/cid\/cis580","volume":"55","author":"Y Taur","year":"2012","unstructured":"Taur, Y. et al. Intestinal domination and the risk of bacteremia in patients undergoing allogeneic hematopoietic stem cell transplantation. Clin. Infect. Dis. 55, 905\u2013914 (2012).","journal-title":"Clin. Infect. Dis."},{"key":"1501_CR14","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1128\/IAI.01197-12","volume":"81","author":"C Ubeda","year":"2013","unstructured":"Ubeda, C. et al. Intestinal microbiota containing Barnesiella species cures vancomycin-resistant Enterococcus faecium colonization. Infect. Immun. 81, 965\u2013973 (2013).","journal-title":"Infect. Immun."},{"key":"1501_CR15","doi-asserted-by":"publisher","first-page":"e1005132","DOI":"10.1371\/journal.ppat.1005132","volume":"11","author":"S Caballero","year":"2015","unstructured":"Caballero, S. et al. Distinct but spatially overlapping intestinal niches for vancomycin-resistant Enterococcus faecium and carbapenem-resistant Klebsiella pneumoniae. PLoS Pathog. 11, e1005132 (2015).","journal-title":"PLoS Pathog."},{"key":"1501_CR16","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1126\/science.1127119","volume":"313","author":"HL Cash","year":"2006","unstructured":"Cash, H. L., Whitham, C. V., Behrendt, C. L. & Hooper, L. V. Symbiotic bacteria direct expression of an intestinal bactericidal lectin. Science 313, 1126\u20131130 (2006).","journal-title":"Science"},{"key":"1501_CR17","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1038\/nature07250","volume":"455","author":"K Brandl","year":"2008","unstructured":"Brandl, K. et al. Vancomycin-resistant enterococci exploit antibiotic-induced innate immune deficits. Nature 455, 804\u2013807 (2008).","journal-title":"Nature"},{"key":"1501_CR18","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1021\/cr030105v","volume":"105","author":"C Chatterjee","year":"2005","unstructured":"Chatterjee, C., Paul, M., Xie, L. & van der Donk, W. A. Biosynthesis and mode of action of lantibiotics. Chem. Rev. 105, 633\u2013684 (2005).","journal-title":"Chem. Rev."},{"key":"1501_CR19","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1146\/annurev-biochem-060110-113521","volume":"81","author":"PJ Knerr","year":"2012","unstructured":"Knerr, P. J. & van der Donk, W. A. Discovery, biosynthesis, and engineering of lantipeptides. Annu. Rev. Biochem. 81, 479\u2013505 (2012).","journal-title":"Annu. Rev. Biochem."},{"key":"1501_CR20","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1038\/154551a0","volume":"154","author":"ATR Mattick","year":"1944","unstructured":"Mattick, A. T. R. & Hirsch, A. A powerful inhibitory substance produced by Group N Streptococci. Nature 154, 551 (1944).","journal-title":"Nature"},{"key":"1501_CR21","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/BF00399424","volume":"69","author":"J Delves-Broughton","year":"1996","unstructured":"Delves-Broughton, J., Blackburn, P., Evans, R. J. & Hugenholtz, J. Applications of the bacteriocin, nisin. Antonie van Leeuwenhoek 69, 193\u2013202 (1996).","journal-title":"Antonie van Leeuwenhoek"},{"key":"1501_CR22","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.1074\/jbc.M006770200","volume":"276","author":"I Wiedemann","year":"2001","unstructured":"Wiedemann, I. et al. Specific binding of nisin to the peptidoglycan precursor lipid II combines pore formation and inhibition of cell wall biosynthesis for potent antibiotic activity. J. Biol. Chem. 276, 1772\u20131779 (2001).","journal-title":"J. Biol. Chem."},{"key":"1501_CR23","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1099\/mic.0.000515","volume":"163","author":"D Hatziioanou","year":"2017","unstructured":"Hatziioanou, D. et al. Discovery of a novel lantibiotic nisin O from Blautia obeum A2-162, isolated from the human gastrointestinal tract. Microbiology 163, 1292\u20131305 (2017).","journal-title":"Microbiology"},{"key":"1501_CR24","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1038\/nsmb830","volume":"11","author":"ST Hsu","year":"2004","unstructured":"Hsu, S. T. et al. The nisin\u2013lipid II complex reveals a pyrophosphate cage that provides a blueprint for novel antibiotics. Nat. Struct. Mol. Biol. 11, 963\u2013967 (2004).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"1501_CR25","doi-asserted-by":"publisher","first-page":"6968","DOI":"10.1021\/bi970008u","volume":"36","author":"E Breukink","year":"1997","unstructured":"Breukink, E. et al. The C-terminal region of nisin is responsible for the initial interaction of nisin with the target membrane. Biochemistry 36, 6968\u20136976 (1997).","journal-title":"Biochemistry"},{"key":"1501_CR26","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1111\/j.1574-6941.2011.01069.x","volume":"76","author":"A Dobson","year":"2011","unstructured":"Dobson, A. et al. Fate and efficacy of lacticin 3147-producing Lactococcus lactis in the mammalian gastrointestinal tract. FEMS Microbiol. Ecol. 76, 602\u2013614 (2011).","journal-title":"FEMS Microbiol. Ecol."},{"key":"1501_CR27","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1111\/j.1365-2036.2005.02615.x","volume":"22","author":"C Picard","year":"2005","unstructured":"Picard, C. et al. Review article: bifidobacteria as probiotic agents \u2014 physiological effects and clinical benefits. Aliment. Pharmacol. Ther. 22, 495\u2013512 (2005).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"1501_CR28","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1046\/j.1365-2672.1999.00620.x","volume":"29","author":"DH Kang","year":"1999","unstructured":"Kang, D. H. & Fung, D. Y. Reduction of Escherichia coli O157:H7 by stimulated Pediococcus acidilactici. Lett. Appl. Microbiol. 29, 206\u2013210 (1999).","journal-title":"Lett. Appl. Microbiol."},{"key":"1501_CR29","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.beha.2015.10.013","volume":"28","author":"Y Taur","year":"2015","unstructured":"Taur, Y., Jenq, R. R., Ubeda, C., van den Brink, M. & Pamer, E. G. Role of intestinal microbiota in transplantation outcomes. Best Pract. Res. Clin. Haematol. 28, 155\u2013161 (2015).","journal-title":"Best Pract. Res. Clin. Haematol."},{"key":"1501_CR30","doi-asserted-by":"publisher","first-page":"eaah4680","DOI":"10.1126\/scitranslmed.aah4680","volume":"9","author":"T Nakatsuji","year":"2017","unstructured":"Nakatsuji, T. et al. Antimicrobials from human skin commensal bacteria protect against Staphylococcus aureus and are deficient in atopic dermatitis. Sci. Transl. Med. 9, eaah4680 (2017).","journal-title":"Sci. Transl. Med."},{"key":"1501_CR31","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1126\/science.1209791","volume":"334","author":"S Vaishnava","year":"2011","unstructured":"Vaishnava, S. et al. The antibacterial lectin RegIII\u03b3 promotes the spatial segregation of microbiota and host in the intestine. Science 334, 255\u2013258 (2011).","journal-title":"Science"},{"key":"1501_CR32","doi-asserted-by":"publisher","first-page":"3380","DOI":"10.1128\/JCM.43.7.3380-3389.2005","volume":"43","author":"A Swidsinski","year":"2005","unstructured":"Swidsinski, A., Weber, J., Loening-Baucke, V., Hale, L. P. & Lochs, H. Spatial organization and composition of the mucosal flora in patients with inflammatory bowel disease. J. Clin. Microbiol. 43, 3380\u20133389 (2005).","journal-title":"J. Clin. Microbiol."},{"key":"1501_CR33","doi-asserted-by":"publisher","first-page":"2338","DOI":"10.1021\/ja109044r","volume":"133","author":"Y Shi","year":"2011","unstructured":"Shi, Y., Yang, X., Garg, N. & van der Donk, W. A. Production of lantipeptides in Escherichia coli. J. Am. Chem. Soc. 133, 2338\u20132341 (2011).","journal-title":"J. Am. Chem. Soc."},{"key":"1501_CR34","unstructured":"Montalban-Lopez, M., Buivydas, A. & Kuipers, O. P. in Hydrocarbon and Lipid Microbiology Protocols Springer Protocols Handbooks (eds McGenity, T. et al.) (Springer, 2015)."},{"key":"1501_CR35","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1038\/ismej.2012.8","volume":"6","author":"JG Caporaso","year":"2012","unstructured":"Caporaso, J. G. et al. Ultra-high-throughput microbial community analysis on the Illumina HiSeq and MiSeq platforms. ISME J. 6, 1621\u20131624 (2012).","journal-title":"ISME J."},{"key":"1501_CR36","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1038\/nmeth.2604","volume":"10","author":"RC Edgar","year":"2013","unstructured":"Edgar, R. C. UPARSE: highly accurate OTU sequences from microbial amplicon reads. Nat. Methods 10, 996\u2013998 (2013).","journal-title":"Nat. Methods"},{"key":"1501_CR37","doi-asserted-by":"publisher","first-page":"3476","DOI":"10.1093\/bioinformatics\/btv401","volume":"31","author":"RC Edgar","year":"2015","unstructured":"Edgar, R. C. & Flyvbjerg, H. Error filtering, pair assembly and error correction for next-generation sequencing reads. Bioinformatics 31, 3476\u20133482 (2015).","journal-title":"Bioinformatics"},{"key":"1501_CR38","doi-asserted-by":"publisher","first-page":"3872","DOI":"10.1093\/nar\/gkv278","volume":"43","author":"T Tatusova","year":"2015","unstructured":"Tatusova, T., Ciufo, S., Fedorov, B., O\u2019Neill, K. & Tolstoy, I. RefSeq microbial genomes database: new representation and annotation strategy. Nucleic Acids Res. 43, 3872 (2015).","journal-title":"Nucleic Acids Res."},{"key":"1501_CR39","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1093\/bioinformatics\/btu170","volume":"30","author":"AM Bolger","year":"2014","unstructured":"Bolger, A. M., Lohse, M. & Usadel, B. Trimmomatic: a flexible trimmer for Illumina sequence data. Bioinformatics 30, 2114\u20132120 (2014).","journal-title":"Bioinformatics"},{"key":"1501_CR40","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/978-1-4939-7463-4_4","volume":"1704","author":"AR Wattam","year":"2018","unstructured":"Wattam, A. R. et al. Assembly, annotation, and comparative genomics in PATRIC, the All Bacterial Bioinformatics Resource Center. Methods Mol. Biol. 1704, 79\u2013101 (2018).","journal-title":"Methods Mol. Biol."},{"key":"1501_CR41","doi-asserted-by":"publisher","first-page":"W339","DOI":"10.1093\/nar\/gkr466","volume":"39","author":"MH Medema","year":"2011","unstructured":"Medema, M. H. et al. antiSMASH: rapid identification, annotation and analysis of secondary metabolite biosynthesis gene clusters in bacterial and fungal genome sequences. Nucleic Acids Res. 39, W339\u2013W346 (2011).","journal-title":"Nucleic Acids Res."},{"key":"1501_CR42","doi-asserted-by":"publisher","first-page":"W273","DOI":"10.1093\/nar\/gkl237","volume":"34","author":"A de Jong","year":"2006","unstructured":"de Jong, A., van Hijum, S. A., Bijlsma, J. J., Kok, J. & Kuipers, O. P. BAGEL: a web-based bacteriocin genome mining tool. Nucleic Acids Res. 34, W273\u2013W279 (2006).","journal-title":"Nucleic Acids Res."},{"key":"1501_CR43","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/nmeth.3176","volume":"12","author":"B Buchfink","year":"2015","unstructured":"Buchfink, B., Xie, C. & Huson, D. H. Fast and sensitive protein alignment using DIAMOND. Nat. Methods 12, 59\u201360 (2015).","journal-title":"Nat. Methods"},{"key":"1501_CR44","doi-asserted-by":"publisher","first-page":"e1002195","DOI":"10.1371\/journal.pcbi.1002195","volume":"7","author":"SR Eddy","year":"2011","unstructured":"Eddy, S. R. Accelerated profile HMM searches. PLOS Comput. Biol. 7, e1002195 (2011).","journal-title":"PLOS Comput. Biol."}],"container-title":["Nature"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41586-019-1501-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41586-019-1501-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41586-019-1501-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T17:58:38Z","timestamp":1684605518000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41586-019-1501-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,21]]},"references-count":44,"journal-issue":{"issue":"7771","published-print":{"date-parts":[[2019,8,29]]}},"alternative-id":["1501"],"URL":"https:\/\/doi.org\/10.1038\/s41586-019-1501-z","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.736468882.793567769","asserted-by":"object"}]},"ISSN":["0028-0836","1476-4687"],"issn-type":[{"value":"0028-0836","type":"print"},{"value":"1476-4687","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,21]]},"assertion":[{"value":"22 October 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"K.H. is co-founder and scientific advisor to Vedanta Biosciences. M.R.M.v.d.B. is on the advisory board of and has financial holdings in Seres Therapeutics Inc., serves on the DKMS medical council, has received speaker honoraria from Merck and Acute Leukemia Forum, holds patents that receive royalties from Seres Therapeutics Inc., has received honorarium and research support (1 January 2017 to present) from Seres Therapeutic Inc., and IP licensing with Seres Therapeutics Inc. and Juno. J.U.P. reports research funding, intellectual property fees, and travel reimbursement from Seres Therapeutics. E.G.P. has received speaker honoraria from Bristol-Myer Squibb, Celgene, Seres Therapeutics, MedImmune, Novartis, and Ferring Pharmaceuticals; is an inventor on patent application no. WPO2015179437A1, entitled \u2018Methods and compositions for reducing <i>Clostridium difficile<\/i> infection\u2019 and no. WPO2017091753A1, entitled \u2018Methods and compositions for reducing vancomycin-resistant <i>Enterococci<\/i> infection or colonization\u2019; and holds patents that receive royalties from Seres Therapeutics Inc.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}